MDT
$88.44
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Recent News
Medtronic (MDT) Strengthens Neurovascular Platform with Scientia Vascular Purchase
Medtronic plc (NYSE:MDT) is included among the 14 Quality Stocks with Highest Dividends. On March 10, Medtronic plc (NYSE:MDT) announced that it had agreed to acquire Scientia Vascular for about $550 million, with additional payments tied to future milestones. Scientia is a private company based in Utah. It has developed specialized guidewires and catheters that […]
Assessing Medtronic (MDT) Valuation After Recent Share Weakness And Modest Undervaluation Claims
Medtronic stock triggered by recent performance metrics Medtronic (MDT) is drawing attention after recent share performance, with the stock around $88.44 and returns showing an 11.1% decline over the past month and a 10.0% decline over the past 3 months. See our latest analysis for Medtronic. Short term momentum has faded, with the 30 day share price return of 11.1% and the year to date share price return of 7.9% both weaker than the relatively modest 1 year total shareholder return of a 1.1%...
Worried the AI Hype Won't Last? These Dividend Stocks Offer Safer Exposure
You don't have to go all in to profit from AI.
NVIDIA Rises as CEO Jensen Huang Takes the Stage at GTC Event
NVIDIA (NASDAQ:NVDA) stock rallied as much as 4% today, with shares touching $188 before pulling back but still closing firmly in the green. The move came as CEO Jensen Huang took the stage at the company’s annual GTC developer conference in San Jose, California. GTC runs March 16 through 19, and Huang’s keynote has historically been ... NVIDIA Rises as CEO Jensen Huang Takes the Stage at GTC Event
Vicarious Surgical applies for Nasdaq listing
The robotics company reduced its 2026 cash burn forecast and said its development timeline remains on track, with a system design freeze expected by year-end.